Overexpression of histone deacetylases in cancer cells is controlled by interplay of transcription factors and epigenetic modulators

FASEB Journal

Volumn 28, Issue 10, 2014, Pages 4265-4279

  Yang, Hui ^a   Salz, Tal ^b   Zajac Kaye, Maria ^a   Liao, Daiqing ^a   Huang, Suming ^a,b   Qiu, Yi ^a  

^a Department of Anatomy and Cell Biology ^*  (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

P300; SET1; Sp1; Sp3

Indexed keywords

HISTONE ACETYLTRANSFERASE PCAF; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE SET1; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; UNCLASSIFIED DRUG; HDAC1 PROTEIN, HUMAN; HDAC2 PROTEIN, HUMAN; HISTONE LYSINE METHYLTRANSFERASE; SETD1A PROTEIN, HUMAN;

ARTICLE; BINDING AFFINITY; CANCER PATIENT; CONTROLLED STUDY; ENZYME BINDING; EPIGENETIC REPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; HCT116 CELL LINE; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; TRANSCRIPTION REGULATION; COLON TUMOR; GENETIC EPIGENESIS; GENETICS; HT 29 CELL LINE; METABOLISM;

COLONIC NEOPLASMS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE-LYSINE N-METHYLTRANSFERASE; HT29 CELLS; HUMANS; P300-CBP TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC;

EID: 84907697952     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-250654     Document Type: Article

References (58)

1. Lee, J. S., Smith, E., and Shilatifard, A. (2010) The language of histone crosstalk. Cell 142, 682-685
2. Ruthenburg, A. J., Allis, C. D., and Wysocka, J. (2007) Methylation of lysine 4 on histone H3: intricacy of writing and readinga single epigenetic mark. Mol. Cell 25, 15-30
3. Heintzman, N. D., Stuart, R. K., Hon, G., Fu, Y., Ching, C. W., Hawkins, R. D., Barrera, L. O., Van Calcar, S., Qu, C., Ching, K. A., Wang, W., Weng, Z., Green, R. D., Crawford, G. E., and Ren, B. (2007) Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 39, 311-318
4. Suva, M. L., Riggi, N., and Bernstein, B. E. (2013) Epigenetic reprogramming in cancer. Science 339, 1567-1570
5. Dawson, M.A., and Kouzarides, T. (2012) Cancer epigenetics: from mechanism to therapy. Cell 150, 12-27
6. Yang, X. J., and Seto, E. (2007) HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 26, 5310-5318
7. Wilson, A. J., Byun, D. S., Popova, N., Murray, L. B., L'Italien, K., Sowa, Y., Arango, D., Velcich, A., Augenlicht, L. H., and Mariadason, J. M. (2006) Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J. Biol. Chem. 281, 13548-13558
8. Huang, B. H., Laban, M., Leung, C.H., Lee, L., Lee, C. K., Salto-Tellez, M., Raju, G. C., and Hooi, S. C. (2005) Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1. Cell Death Differ. 12, 395-404
9. Zhu, P., Huber, E., Kiefer, F., and Gottlicher, M. (2004) Specific and redundant functions of histone deacetylases in regulation of cell cycle and apoptosis. Cell Cycle 3, 1240-1242
10. Ishihama, K., Yamakawa, M., Semba, S., Takeda, H., Kawata, S., Kimura, S., and Kimura, W. (2007) Expression of HDAC1 and CBP/p300 in human colorectal carcinomas. J. Clin. Pathol. 60, 1205-1210
11. Haberland, M., Johnson, A., Mokalled, M. H., Montgomery, R. L., and Olson, E. N. (2009) Genetic dissection of histone deacetylase requirement in tumor cells. Proc. Natl. Acad. Sci. U. S. A. 106, 7751-7755
12. Ropero, S., and Esteller, M. (2007) The role of histone deacetylases (HDACs) in human cancer. Mol. Oncol. 1, 19-25
13. Choi, J. H., Kwon, H. J., Yoon, B. I., Kim, J. H., Han, S. U., Joo, H. J., and Kim, D. Y. (2001) Expression profile of histone deacetylase 1 in gastric cancer tissues. Jpn. J. Cancer Res. 92, 1300-1304
14. Halkidou, K., Gaughan, L., Cook, S., Leung, H. Y., Neal, D. E., and Robson, C. N. (2004) Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer. Prostate 59, 177-189
15. Spange, S., Wagner, T., Heinzel, T., and Kramer, O. H. (2009) Acetylation of non-histone proteins modulates cellular signalling at multiple levels. Int. J. Biochem. Cell Biol. 41, 185-198
16. Brunmeir, R., Lagger, S., and Seiser, C. (2009) Histone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation. Int. J. Dev. Biol. 53, 275-289
17. Senese, S., Zaragoza, K., Minardi, S., Muradore, I., Ronzoni, S., Passafaro, A., Bernard, L., Draetta, G. F., Alcalay, M., Seiser, C., and Chiocca, S. (2007) Role for histone deacetylase 1 in human tumor cell proliferation. Mol. Cell. Biol. 27, 4784-4795
18. Salz, T., Li, G., Kaye, F. J., Zhou, L., Qiu, Y., and Huang, S. (2014) hSETD1A regulates Wnt target genes and controls tumor growth of colorectal cancer cells. Cancer Res. 74, 775-786
19. Akhtar-Zaidi, B., Cowper-Sal-lari, R., Corradin, O., Saiakhova, A., Bartels, C. F., Balasubramanian, D., Myeroff, L., Lutterbaugh, J., Jarrar, A., Kalady, M. F., Willis, J., Moore, J. H., Tesar, P. J., Laframboise, T., Markowitz, S., Lupien, M., and Scacheri, P. C. (2012) Epigenomic enhancer profiling defines a signature of colon cancer. Science 336, 736-739
20. Enroth, S., Rada-Iglesisas, A., Andersson, R., Wallerman, O., Wanders, A., Pahlman, L., Komorowski, J., and Wadelius, C. (2011) Cancer associated epigenetic transitions identified by genome-wide histone methylation binding profiles in human colorectal cancer samples and paired normal mucosa. BMC Cancer 11, 450
21. Gayther, S. A., Batley, S. J., Linger, L., Bannister, A., Thorpe, K., Chin, S. F., Daigo, Y., Russell, P., Wilson, A., Sowter, H. M., Delhanty, J. D., Ponder, B. A., Kouzarides, T., and Caldas, C. (2000) Mutations truncating the EP300 acetylase in human cancers. Nat. Genet. 24, 300-303
22. Gu, W., and Roeder, R. G. (1997) Activation of p53 sequencespecific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606
23. Yuan, Z. L., Guan, Y. J., Chatterjee, D., and Chin, Y. E. (2005) Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science 307, 269-273
24. Marotta, L. L., Almendro, V., Marusyk, A., Shipitsin, M., Schemme, J., Walker, S. R., Bloushtain-Qimron, N., Kim, J. J., Choudhury, S. A., Maruyama, R., Wu, Z., Gonen, M., Mulvey, L. A., Bessarabova, M. O., Huh, S. J., Silver, S. J., Kim, S. Y., Park, S. Y., Lee, H. E., Anderson, K. S., Richardson, A. L., Nikolskaya, T., Nikolsky, Y., Liu, X. S., Root, D. E., Hahn, W. C., Frank, D. A., and Polyak, K. (2011) The JAK2/STAT3 signaling pathway is required for growth of CD44(+)CD24(-) stem cell-like breast cancer cells in human tumors. J. Clin. Invest. 121, 2723-2735
25. Chen, L. F., Mu, Y., and Greene, W. C. (2002) Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J. 21, 6539-6548
26. Loboda, A., Jozkowicz, A., and Dulak, J. (2010) HIF-1 and HIF-2 transcription factors-similar but not identical. Mol. Cell 29, 435-442
27. Yang, Y., Rao, R., Shen, J., Tang, Y., Fiskus, W., Nechtman, J., Atadja, P., and Bhalla, K. (2008) Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion. Cancer Res. 68, 4833-4842
28. Iyer, N. G., Xian, J., Chin, S. F., Bannister, A. J., Daigo, Y., Aparicio, S., Kouzarides, T., and Caldas, C. (2007) p300 is required for orderly G1/S transition in human cancer cells. Oncogene 26, 21-29
29. Ait-Si-Ali, S., Polesskaya, A., Filleur, S., Ferreira, R., Duquet, A., Robin, P., Vervish, A., Trouche, D., Cabon, F., and Harel-Bellan, A. (2000) CBP/p300 histone acetyl-transferase activity is important for the G1/S transition. Oncogene 19, 2430-2437
30. Suske, G. (1999) The Sp-family of transcription factors. Gene 238, 291-300
31. Li, L., and Davie, J. R. (2010) The role of Sp1 and Sp3 in normal and cancer cell biology. Ann. Anat. 192, 275-283
32. Wilson, A. J., Chueh, A. C., Togel, L., Corner, G. A., Ahmed, N., Goel, S., Byun, D. S., Nasser, S., Houston, M.A., Jhawer, M., Smartt, H. J., Murray, L. B., Nicholas, C., Heerdt, B. G., Arango, D., Augenlicht, L. H., and Mariadason, J. M. (2010) Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction. Cancer Res. 70, 609-620
33. Chu, E., Koeller, D. M., Johnston, P. G., Zinn, S., and Allegra, C. J. (1993) Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma. Mol. Pharmacol. 43, 527-533
34. Willson, J. K., Bittner, G. N., Oberley, T. D., Meisner, L. F., and Weese, J. L. (1987) Cell culture of human colon adenomas and carcinomas. Cancer Res. 47, 2704-2713
35. Matys, V., Fricke, E., Geffers, R., Gossling, E., Haubrock, M., Hehl, R., Hornischer, K., Karas, D., Kel, A. E., Kel-Margoulis, O. V., Kloos, D. U., Land, S., Lewicki-Potapov, B., Michael, H., Munch, R., Reuter, I., Rotert, S., Saxel, H., Scheer, M., Thiele, S., and Wingender, E. (2003) TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 31, 374-378
36. Schuettengruber, B., Simboeck, E., Khier, H., and Seiser, C. (2003) Autoregulation of mouse histone deacetylase 1 expression. Mol. Cell. Biol. 23, 6993-7004
37. Wada, T., Kikuchi, J., Nishimura, N., Shimizu, R., Kitamura, T., and Furukawa, Y. (2009) Expression levels of histone deacetylases determine the cell fate of hematopoietic progenitors. J. Biol. Chem. 284, 30673-30683
38. Yang, T., Jian, W., Luo, Y., Fu, X., Noguchi, C., Bungert, J., Huang, S., and Qiu, Y. (2012) Acetylation of histone deacetylase 1 regulates NuRD corepressor complex activity. J. Biol. Chem.287, 40279-40291
39. Pugh, B. F., and Tjian, R. (1991) Transcription from a TATAless promoter requires a multisubunit TFIID complex. Genes Dev. 5, 1935-1945
40. Zeng, Y., Tang, C. M., Yao, Y. L., Yang, W. M., and Seto, E. (1998) Cloning and characterization of the mouse histone deacetylase-2 gene. J. Biol. Chem. 273, 28921-28930
41. Valin, A., Ouyang, J., and Gill, G. (2013) Transcription factor Sp3 represses expression of p21CIP(1) via inhibition of productive elongation by RNA polymerase II. Mol. Cell. Biol. 33, 1582-1593
42. Billon, N., Carlisi, D., Datto, M. B., van Grunsven, L. A., Watt, A., Wang, X. F., and Rudkin, B. B. (1999) Cooperation of Sp1 and p300 in the induction of the CDK inhibitor p21WAF1/CIP1 during NGF-mediated neuronal differentiation. Oncogene 18, 2872-2882
43. Doetzlhofer, A., Rotheneder, H., Lagger, G., Koranda, M., Kurtev, V., Brosch, G., Wintersberger, E., and Seiser, C. (1999) Histone deacetylase 1 can repress transcription by binding to Sp1. Mol. Cell. Biol. 19, 5504-5511
44. Xiao, H., Hasegawa, T., and Isobe, K. (2000) p300 collaborates with Sp1 and Sp3 in p21(waf1/cip1) promoter activation induced by histone deacetylase inhibitor. J. Biol. Chem. 275, 1371-1376
45. Waby, J. S., Chirakkal, H., Yu, C., Griffiths, G. J., Benson, R. S., Bingle, C. D., and Corfe, B. M. (2010) Sp1 acetylation is associated with loss of DNA binding at promoters associated with cell cycle arrest and cell death in a colon cell line. Mol. Cancer 9, 275
46. Hung, J. J., Wang, Y. T., and Chang, W. C. (2006) Sp1 deacetylation induced by phorbol ester recruits p300 to activate 12(S)-lipoxygenase gene transcription. Mol. Cell. Biol. 26, 1770-1785
47. Higashijima, J., Kurita, N., Miyatani, T., Yoshikawa, K., Morimoto, S., Nishioka, M., Iwata, T., and Shimada, M. (2011) Expression of histone deacetylase 1 and metastasis-associated protein 1 as prognostic factors in colon cancer. Oncol. Rep. 26, 343-348
48. Weichert, W., Roske, A., Niesporek, S., Noske, A., Buckendahl, A. C., Dietel, M., Gekeler, V., Boehm, M., Beckers, T., and Denkert, C. (2008) Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo. Clin. Cancer Res. 14, 1669-1677
49. Liu, L., Chen, B., Qin, S., Li, S., He, X., Qiu, S., Zhao, W., and Zhao, H. (2010) A novel histone deacetylase inhibitor Chidamide induces apoptosis of human colon cancer cells. Biochem. Biophys. Res. Commun. 392, 190-195
50. Meng, J., Zhang, H. H., Zhou, C. X., Li, C., Zhang, F., and Mei, Q. B. (2012) The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and-independent pathways. Oncol. Rep. 28, 384-388
51. Bracker, T. U., Sommer, A., Fichtner, I., Faus, H., Haendler, B., and Hess-Stumpp, H. (2009) Efficacy of MS-275, a selective inhibitor of class I histone deacetylases, in human colon cancer models. Int. J. Oncol. 35, 909-920
52. Flatmark, K., Nome, R. V., Folkvord, S., Bratland, A., Rasmussen, H., Ellefsen, M. S., Fodstad, O., and Ree, A. H. (2006) Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition. Radiat. Oncol. 1, 25
53. Abaza, M. S., Bahman, A. M., Al-Attiyah, R. J., and Kollamparambil, A. M. (2012) Synergistic induction of apoptosis and chemosensitization of human colorectal cancer cells by histone deacetylase inhibitor, scriptaid, and proteasome inhibitors: potential mechanisms of action. Tumour Biol. 33, 1951-1972
54. Azizkhan, J. C., Jensen, D. E., Pierce, A. J., and Wade, M. (1993) Transcription from TATA-less promoters: dihydrofolate reductase as a model. Crit. Rev. Eukaryot. Gene Expr. 3, 229-254
55. Ma, W., Horvath, G. C., Kistler, M. K., and Kistler, W. S. (2008) Expression patterns of SP1 and SP3 during mouse spermatogenesis: SP1 down-regulation correlates with two successive promoter changes and translationally compromised transcripts. Biol. Reprod. 79, 289-300
56. Martin, D. G., Baetz, K., Shi, X., Walter, K. L., MacDonald, V. E., Wlodarski, M. J., Gozani, O., Hieter, P., and Howe, L. (2006) The Yng1p plant homeodomain finger is a methyl-histone binding module that recognizes lysine 4-methylated histone H3. Mol. Cell. Biol. 26, 7871-7879
57. Taverna, S. D., Ilin, S., Rogers, R. S., Tanny, J. C., Lavender, H., Li, H., Baker, L., Boyle, J., Blair, L. P., Chait, B. T., Patel, D. J., Aitchison, J. D., Tackett, A. J., and Allis, C. D. (2006) Yng1 PHD finger binding to H3 trimethylated at K4 promotes NuA3 HAT activity at K14 of H3 and transcription at a subset of targeted ORFs. Mol. Cell 24, 785-796
58. Tang, Z., Chen, W. Y., Shimada, M., Nguyen, U. T., Kim, J., Sun, X. J., Sengoku, T., McGinty, R. K., Fernandez, J. P., Muir, T. W., and Roeder, R. G. (2013) SET1 and p300 act synergistically, through coupled histone modifications, in transcriptional activation by p53. Cell 154, 297-310